TipRanks
Medistim ASA (GB:0OCD)
LSE:0OCD
UK Market
0OCD
Medistim ASA
RESEARCH TOOLSreports

Medistim ASA (0OCD) Ratios

0 Followers

Medistim ASA Ratios

GB:0OCD's free cash flow for Q2 2026 was kr0.54. For the 2026 fiscal year, GB:0OCD's free cash flow was decreased by kr and operating cash flow was kr0.32. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.15 3.34 4.00 4.15 3.87
Quick Ratio
 1.88 2.21 2.50 2.61 2.72
Cash Ratio
 0.81 1.48 1.67 1.63 1.44
Solvency Ratio
 1.08 0.95 0.93 1.18 1.14
Operating Cash Flow Ratio
 1.55 1.31 1.33 1.20 1.14
Short-Term Operating Cash Flow Coverage
 16.39 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 216.54Mkr 285.53Mkr 290.77Mkr 283.79Mkr 270.93M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.07 0.06 0.03 0.04
Debt-to-Equity Ratio
 0.11 0.11 0.08 0.04 0.05
Debt-to-Capital Ratio
 0.10 0.10 0.07 0.04 0.04
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.42 1.41 1.32 1.27 1.31
Debt Service Coverage Ratio
 4.72 26.87 272.70 215.90 342.06
Interest Coverage Ratio
 8.32 30.78 285.57 229.39 366.89
Debt to Market Cap
 <0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
 3.89 3.04 1.90 0.99 0.96
Net Debt to EBITDA
 -0.24 -0.74 -0.93 -0.88 -0.78
Profitability Margins
Gross Profit Margin
55.33%45.90%79.79%78.45%78.10%
EBIT Margin
26.58%30.45%23.30%25.22%30.11%
EBITDA Margin
29.23%31.28%27.65%29.76%33.68%
Operating Profit Margin
27.26%28.04%23.30%25.22%29.05%
Pretax Profit Margin
28.46%29.56%23.86%25.95%30.04%
Net Profit Margin
21.96%22.75%18.46%19.92%23.44%
Continuous Operations Profit Margin
21.96%22.75%18.46%19.92%23.44%
Net Income Per EBT
77.16%76.97%77.34%76.79%78.04%
EBT Per EBIT
104.37%105.43%102.42%102.87%103.40%
Return on Assets (ROA)
28.40%24.10%18.06%20.53%23.61%
Return on Equity (ROE)
36.64%33.99%23.78%26.09%31.00%
Return on Capital Employed (ROCE)
44.72%37.92%28.03%31.95%36.90%
Return on Invested Capital (ROIC)
33.66%28.55%21.26%24.04%28.27%
Return on Tangible Assets
35.22%27.71%20.14%22.55%25.52%
Earnings Yield
3.57%3.36%3.79%2.65%2.70%
Efficiency Ratios
Receivables Turnover
 5.75 6.70 7.21 7.01 4.61
Payables Turnover
 0.00 14.22 6.41 4.48 4.35
Inventory Turnover
 2.15 2.35 0.71 0.77 0.93
Fixed Asset Turnover
 9.19 7.99 7.69 9.09 9.48
Asset Turnover
 1.29 1.06 0.98 1.03 1.01
Working Capital Turnover Ratio
 2.40 2.13 1.82 1.79 1.89
Cash Conversion Cycle
 233.28 184.19 509.10 443.14 387.23
Days of Sales Outstanding
 63.44 54.51 50.63 52.04 79.21
Days of Inventory Outstanding
 169.83 155.35 515.39 472.64 391.90
Days of Payables Outstanding
 0.00 25.67 56.93 81.54 83.88
Operating Cycle
 233.28 209.86 566.02 524.68 471.11
Cash Flow Ratios
Operating Cash Flow Per Share
 10.39 10.24 7.81 6.18 6.22
Free Cash Flow Per Share
 7.78 9.94 7.48 4.56 5.06
CapEx Per Share
 6.22 0.30 0.33 1.62 1.16
Free Cash Flow to Operating Cash Flow
 0.75 0.97 0.96 0.74 0.81
Dividend Paid and CapEx Coverage Ratio
 0.73 1.63 1.62 1.01 1.27
Capital Expenditure Coverage Ratio
 1.67 34.06 23.58 3.81 5.38
Operating Cash Flow Coverage Ratio
 4.10 3.80 4.16 6.42 6.63
Operating Cash Flow to Sales Ratio
 0.25 0.27 0.25 0.22 0.23
Free Cash Flow Yield
3.08%3.84%5.01%2.13%2.19%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 28.02 29.74 26.37 37.74 36.98
Price-to-Sales (P/S) Ratio
 6.14 6.76 4.87 7.52 8.67
Price-to-Book (P/B) Ratio
 11.26 10.11 6.27 9.85 11.46
Price-to-Free Cash Flow (P/FCF) Ratio
 32.50 26.07 19.98 46.95 45.62
Price-to-Operating Cash Flow Ratio
 24.34 25.30 19.13 34.62 37.14
Price-to-Earnings Growth (PEG) Ratio
 1.07 0.55 0.00 -4.07 1.46
Price-to-Fair Value
 11.26 10.11 6.27 9.85 11.46
Enterprise Value Multiple
 20.78 20.88 16.67 24.39 24.96
Enterprise Value
 4.57B 4.57B 2.59B 3.78B 4.09B
EV to EBITDA
 20.78 20.88 16.67 24.39 24.96
EV to Sales
 6.07 6.53 4.61 7.26 8.41
EV to Free Cash Flow
 32.12 25.17 18.92 45.32 44.25
EV to Operating Cash Flow
 24.04 24.43 18.12 33.42 36.02
Tangible Book Value Per Share
 16.31 20.92 20.60 19.25 18.17
Shareholders’ Equity Per Share
 22.47 25.63 23.84 21.73 20.15
Tax and Other Ratios
Effective Tax Rate
 0.23 0.23 0.23 0.23 0.22
Revenue Per Share
 41.15 38.29 30.72 28.46 26.65
Net Income Per Share
 9.04 8.71 5.67 5.67 6.25
Tax Burden
 0.77 0.77 0.77 0.77 0.78
Interest Burden
 1.07 0.97 1.02 1.03 1.00
Research & Development to Revenue
 0.05 0.06 0.06 0.03 0.03
SG&A to Revenue
 0.18 0.09 0.11 0.28 0.06
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.15 1.18 1.38 1.09 1.00
Currency in NOK